STARGARDT-LIKE MACULAR DYSTROPHY
Clinical trials for STARGARDT-LIKE MACULAR DYSTROPHY explained in plain language.
Never miss a new study
Get alerted when new STARGARDT-LIKE MACULAR DYSTROPHY trials appear
Sign up with your email to follow new studies for STARGARDT-LIKE MACULAR DYSTROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Eye disease study tracks vision loss in stargardt patients
Knowledge-focused Recruiting nowThis study follows 90 children and adults with Stargardt disease or similar inherited eye conditions to see how their vision changes over 2 years. Participants will have regular eye exams and imaging every 6 months. No treatment is given—the goal is to better understand the natur…
Matched conditions: STARGARDT-LIKE MACULAR DYSTROPHY
Sponsor: Astellas Pharma Global Development, Inc. • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC
-
Scientists track rare eye disease to pave way for future treatments
Knowledge-focused Recruiting nowThis study follows 25 people aged 10 and older with Stargardt-like macular dystrophy (STDG3), a rare inherited eye disease that causes vision loss. Over three years, researchers will measure changes in the retina using eye exams, imaging, and vision tests. The goal is to understa…
Matched conditions: STARGARDT-LIKE MACULAR DYSTROPHY
Sponsor: National Eye Institute (NEI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC